| Description | Gantenerumab, a fully human IgG1 monoclonal antibody targeting amyloid-β (Aβ), exhibits sustained binding to cerebral Aβ. It is employed in research focused on Alzheimer's disease [1]. |
| molecular weight | N/A |
| CAS | 1043556-46-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |